These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3687878)

  • 21. A comparison of rapid (opioid) detoxification with clonidine-assisted detoxification for heroin-dependent persons.
    Arnold-Reed DE; Hulse GK
    J Opioid Manag; 2005; 1(1):17-23. PubMed ID: 17315407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.
    Azatian A; Papiasvilli A; Joseph H
    J Addict Dis; 1994; 13(1):35-52. PubMed ID: 8018739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clonidine for the treatment of heroin withdrawal syndrome].
    Schanda H; Presslich O; Hermann P
    Wien Klin Wochenschr; 1983 Aug; 95(16):569-72. PubMed ID: 6649643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Golden SA; Sakhrani DL
    J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tizanidine in the treatment of acute withdrawal symptoms in heroin dependent patients].
    Sós I; Kiss N; Csorba J; Gerevich J
    Orv Hetil; 2000 Apr; 141(15):783-6. PubMed ID: 10808729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naltrexone and clonidine in heroin withdrawal treatment.
    Drummond DC; Turkington D
    Br J Psychiatry; 1989 Apr; 154():571-2. PubMed ID: 2629740
    [No Abstract]   [Full Text] [Related]  

  • 27. 24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
    Carreño JE; Bobes J; Brewer C; Alvarez CE; San Narciso GI; Bascarán MT; Sánchez del Río J
    Addict Biol; 2002 Apr; 7(2):243-50. PubMed ID: 12006220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone induction: psychologic and pharmacologic strategies.
    Kleber HD; Kosten TR
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):29-38. PubMed ID: 6469934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
    J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
    McGregor C; Ali R; White JM; Thomas P; Gowing L
    Drug Alcohol Depend; 2002 Sep; 68(1):5-14. PubMed ID: 12167548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
    Oliveros SC; Caballero L; Iruela LM
    Med Clin (Barc); 1990 Nov; 95(16):627-9. PubMed ID: 2097456
    [No Abstract]   [Full Text] [Related]  

  • 32. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Fishman M
    Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three methods of opioid detoxification in a primary care setting. A randomized trial.
    O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ
    Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal.
    Washton AM; Resnick RB; Rawson RA
    NIDA Res Monogr; 1979; 27():233-9. PubMed ID: 121339
    [No Abstract]   [Full Text] [Related]  

  • 35. Current pharmacotherapies for opioid dependence.
    Kosten TR
    Psychopharmacol Bull; 1990; 26(1):69-74. PubMed ID: 2196628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone in addicted business executives and physicians.
    Washton AM; Pottash AC; Gold MS
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):39-41. PubMed ID: 6088468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

  • 38. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of heroin addicts using buprenorphine.
    Kosten TR; Morgan C; Kleber HD
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.